Decentralized data infrastructure Nubila completes $8 million seed round financing, led by Blockspace Force and others
According to ChainCatcher, decentralized data infrastructure Nubila has announced the completion of an $8 million seed round, bringing its total funding to $10.5 million. This round was co-led by Blockspace Force and Quantum Holdings, with participation from IoTeX, Assemblyers, Synharbour AI, and several top protocol founders.
Following the completion of this funding round, Nubila will fully enter the Prediction Oracle sector, aiming to bring more high-value real-world data on-chain and achieve higher accuracy and reliability.
Nubila plans to leverage its data value on platforms such as Polymarket and Kalshi in the future, transforming verified real-world intelligence into on-chain predictive data units. It will provide reliable settlement oracle services for scenarios such as temperature thresholds, extreme events, and real-world data, connecting real-world signals with financial markets to enable transparent trading and hedging.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uniswap.com Domain Story Resurfaces After SBF Purchase Claim
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Crypto prices
More
